FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322603977> ?p ?o ?g. }

• W4322603977 endingPage "e319" @default.
• W4322603977 startingPage "e308" @default.
• W4322603977 abstract "Epidemiological monitoring of HIV among transgender women is minimal despite prioritisation of this group in the US National HIV/AIDS Strategy (2022-2025). We aimed to estimate HIV incidence in a multisite cohort of transgender women in the eastern and southern USA. Participant deaths were identified during follow-up; thus, we felt it was an ethical imperative to report mortality alongside HIV incidence.In this study, we established a multisite cohort across two modes: a site-based, technology-enhanced mode in six cities (Atlanta, Baltimore, Boston, Miami, New York City, and Washington, DC) and an exclusively digital mode that spanned 72 eastern and southern US cities that matched the six site-based cities based on population size and demographics. Trans feminine adults (≥18 years) who were not living with HIV were eligible and followed up for at least 24 months. Participants completed surveys and oral fluid HIV testing with clinical confirmation. We ascertained deaths through community and clinical sources. We estimated HIV incidence and mortality using the number of HIV seroconversions and deaths, respectively, divided by person-years accumulated from enrolment. Logistic regression models were used to identify predictors of HIV seroconversion (primary outcome) or death.Between March 22, 2018, and Aug 31, 2020, we enrolled 1312 participants with 734 (56%) in site-based and 578 (44%) in digital modes. At the 24-month assessment, 633 (59%) of 1076 eligible participants consented to extending participation. 1084 (83%) of 1312 participants were retained at this analysis based on the study definition of loss to follow-up. As of May 25, 2022, the cohort participants had contributed 2730 accumulated person-years to the analytical dataset. Overall HIV incidence was 5·5 (95% CI 2·7-8·3) per 1000 person-years and incidence was higher among Black participants and those living in the south. Nine participants died during the study. The overall mortality rate was 3·3 (95% CI 1·5-6·3) per 1000 person-years, and the rate was higher among Latinx participants. Identical predictors of HIV seroconversion and death included residence in southern cities, sexual partnerships with cisgender men, and use of stimulants. Participation in the digital cohort and seeking care for gender transition were inversely associated with both outcomes.As HIV research and interventions are increasingly delivered online, differences by mode highlight the need for continued community and location-based efforts to reach the most marginalised transgender women. Our findings underscore community calls for interventions that address social and structural contexts that affect survival and other health concerns alongside HIV prevention.National Institutes of Health.For the Spanish translation of the abstract see Supplementary Materials section." @default.
• W4322603977 created "2023-03-01" @default.
• W4322603977 creator A5000051963 @default.
• W4322603977 creator A5000061093 @default.
• W4322603977 creator A5002192906 @default.
• W4322603977 creator A5003243186 @default.
• W4322603977 creator A5015210998 @default.
• W4322603977 creator A5015290437 @default.
• W4322603977 creator A5016918408 @default.
• W4322603977 creator A5017435949 @default.
• W4322603977 creator A5018535457 @default.
• W4322603977 creator A5025150770 @default.
• W4322603977 creator A5039865200 @default.
• W4322603977 creator A5054463066 @default.
• W4322603977 creator A5054796651 @default.
• W4322603977 creator A5064249626 @default.
• W4322603977 creator A5070617032 @default.
• W4322603977 creator A5084196272 @default.
• W4322603977 creator A5087509985 @default.
• W4322603977 creator A5088137326 @default.
• W4322603977 date "2023-05-01" @default.
• W4322603977 modified "2023-10-18" @default.
• W4322603977 title "HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study" @default.
• W4322603977 cites W1906369138 @default.
• W4322603977 cites W2009747821 @default.
• W4322603977 cites W2031905547 @default.
• W4322603977 cites W2168949273 @default.
• W4322603977 cites W2325680222 @default.
• W4322603977 cites W2422326649 @default.
• W4322603977 cites W2474380917 @default.
• W4322603977 cites W2787013801 @default.
• W4322603977 cites W2902418781 @default.
• W4322603977 cites W2907166006 @default.
• W4322603977 cites W2912227521 @default.
• W4322603977 cites W2950032005 @default.
• W4322603977 cites W2953392925 @default.
• W4322603977 cites W2965318943 @default.
• W4322603977 cites W2999504317 @default.
• W4322603977 cites W3005427013 @default.
• W4322603977 cites W3046316787 @default.
• W4322603977 cites W3092957891 @default.
• W4322603977 cites W3122681425 @default.
• W4322603977 cites W3140711993 @default.
• W4322603977 cites W3183710980 @default.
• W4322603977 cites W3190424399 @default.
• W4322603977 cites W3198583374 @default.
• W4322603977 cites W4205124724 @default.
• W4322603977 cites W4223628102 @default.
• W4322603977 cites W4293474604 @default.
• W4322603977 doi "https://doi.org/10.1016/s2352-3018(23)00008-5" @default.
• W4322603977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36868260" @default.
• W4322603977 hasPublicationYear "2023" @default.
• W4322603977 type Work @default.
• W4322603977 citedByCount "5" @default.
• W4322603977 countsByYear W43226039772023 @default.
• W4322603977 crossrefType "journal-article" @default.
• W4322603977 hasAuthorship W4322603977A5000051963 @default.
• W4322603977 hasAuthorship W4322603977A5000061093 @default.
• W4322603977 hasAuthorship W4322603977A5002192906 @default.
• W4322603977 hasAuthorship W4322603977A5003243186 @default.
• W4322603977 hasAuthorship W4322603977A5015210998 @default.
• W4322603977 hasAuthorship W4322603977A5015290437 @default.
• W4322603977 hasAuthorship W4322603977A5016918408 @default.
• W4322603977 hasAuthorship W4322603977A5017435949 @default.
• W4322603977 hasAuthorship W4322603977A5018535457 @default.
• W4322603977 hasAuthorship W4322603977A5025150770 @default.
• W4322603977 hasAuthorship W4322603977A5039865200 @default.
• W4322603977 hasAuthorship W4322603977A5054463066 @default.
• W4322603977 hasAuthorship W4322603977A5054796651 @default.
• W4322603977 hasAuthorship W4322603977A5064249626 @default.
• W4322603977 hasAuthorship W4322603977A5070617032 @default.
• W4322603977 hasAuthorship W4322603977A5084196272 @default.
• W4322603977 hasAuthorship W4322603977A5087509985 @default.
• W4322603977 hasAuthorship W4322603977A5088137326 @default.
• W4322603977 hasConcept C107130276 @default.
• W4322603977 hasConcept C120665830 @default.
• W4322603977 hasConcept C121332964 @default.
• W4322603977 hasConcept C126322002 @default.
• W4322603977 hasConcept C144024400 @default.
• W4322603977 hasConcept C149923435 @default.
• W4322603977 hasConcept C151956035 @default.
• W4322603977 hasConcept C201903717 @default.
• W4322603977 hasConcept C2908647359 @default.
• W4322603977 hasConcept C61511704 @default.
• W4322603977 hasConcept C71924100 @default.
• W4322603977 hasConcept C72563966 @default.
• W4322603977 hasConcept C74909509 @default.
• W4322603977 hasConcept C99454951 @default.
• W4322603977 hasConceptScore W4322603977C107130276 @default.
• W4322603977 hasConceptScore W4322603977C120665830 @default.
• W4322603977 hasConceptScore W4322603977C121332964 @default.
• W4322603977 hasConceptScore W4322603977C126322002 @default.
• W4322603977 hasConceptScore W4322603977C144024400 @default.
• W4322603977 hasConceptScore W4322603977C149923435 @default.
• W4322603977 hasConceptScore W4322603977C151956035 @default.
• W4322603977 hasConceptScore W4322603977C201903717 @default.
• W4322603977 hasConceptScore W4322603977C2908647359 @default.
• W4322603977 hasConceptScore W4322603977C61511704 @default.

• next